Nexentis Technologies NXTS
NASDAQ NXTS
$1.44 +0.01 (+0.70%)
At close: Oct 2, 2026 · 4:00 PM EDT

Nexentis Technologies (NXTS) Cost of Revenue (2019 - 2025)

Updated

Nexentis Technologies' Cost of Revenue came in at $2,000 for Q3 2025, down 97.4% from $77,000 a year earlier and unchanged from the prior quarter.

Analysis

Nexentis Technologies (NXTS) Cost of Revenue (2019 - 2025) Analysis & Trends

Over the trailing twelve months to Sep 30, 2025, Nexentis Technologies reported Cost of Revenue of $73,000, down 23.8% year-over-year; for FY2024, it came in at $165,000, up 200.0% from FY2023.

  • Cost of Revenue carries a five-year compound annual growth rate of 2.7% (FY2019 to FY2024).
  • Going back by year, Cost of Revenue was $55,000 in FY2023 (-65.3%), $158,313 in FY2022 (+16.5%), $135,943 in FY2021 (+213.2%) and $43,405 in FY2020 (-70.0%).
  • The five-year range for quarterly Cost of Revenue is -$15,229 (Q4 2023) to $79,064 (Q4 2022).
  • Year-over-year, Cost of Revenue has declined for three consecutive quarters, with an average decline of 65.3% over the last five quarters.
  • The fastest year-over-year change in Cost of Revenue over five years came in Q4 2021 (growth of 283.8%), and the weakest in Q3 2023 (a decline of 98.0%).
  • Business Quant data shows NXTS's Cost of Revenue at $2,000 (Q2 2025), $14,000 (Q1 2025) and $55,000 (Q4 2024) in the three quarters before Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 Nexentis Technologies 1.18 Mn -21.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 2,000.00
Jun 30, 2025 2,000.00
Mar 31, 2025 14,000.00
Dec 31, 2024 55,000.00
Sep 30, 2024 77,000.00
Jun 30, 2024 6,000.00
Mar 31, 2024 28,000.00
Dec 31, 2023 -15,229.00
Sep 30, 2023 476.00
Jun 30, 2023 27,007.00
Mar 31, 2023 42,746.00
Dec 31, 2022 79,064.00
Sep 30, 2022 24,402.00
Jun 30, 2022 12,998.00
Mar 31, 2022 41,849.00
Dec 31, 2021 68,012.00
Sep 30, 2021 53,644.00
Jun 30, 2021 11,354.00
Mar 31, 2021 2,933.00
Dec 31, 2020 17,719.00
API Access

Nexentis Technologies Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=NXTS&period=max&api_key=YOUR_API_KEY